NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 203 filers reported holding NEVRO CORP in Q2 2017. The put-call ratio across all filers is 1.52 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $1,168,000 | -28.0% | 10,036 | +2.5% | 0.01% | -25.0% |
| Q2 2021 | $1,623,000 | +19.5% | 9,790 | +0.5% | 0.01% | +14.3% |
| Q1 2021 | $1,358,000 | -16.3% | 9,738 | +3.9% | 0.01% | -12.5% |
| Q4 2020 | $1,622,000 | +1348.2% | 9,370 | +659.9% | 0.01% | +300.0% |
| Q3 2017 | $112,000 | +24.4% | 1,233 | +2.2% | 0.00% | +100.0% |
| Q2 2017 | $90,000 | -99.4% | 1,207 | -99.2% | 0.00% | -99.6% |
| Q1 2017 | $14,931,000 | +31668.1% | 159,354 | +24799.1% | 0.25% | +25100.0% |
| Q4 2016 | $47,000 | -92.1% | 640 | -92.8% | 0.00% | -90.0% |
| Q4 2015 | $597,000 | +4.0% | 8,843 | -28.6% | 0.01% | +11.1% |
| Q3 2015 | $574,000 | -35.5% | 12,377 | -25.3% | 0.01% | -25.0% |
| Q2 2015 | $890,000 | -20.7% | 16,567 | -29.2% | 0.01% | -25.0% |
| Q1 2015 | $1,122,000 | +13.8% | 23,404 | -8.2% | 0.02% | +6.7% |
| Q4 2014 | $986,000 | – | 25,508 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Iron Triangle Partners LP | 562,833 | $40,710,000 | 4.84% |
| Altium Capital Management LP | 77,000 | $5,569,000 | 1.86% |
| PFM Health Sciences, LP | 649,513 | $46,979,000 | 1.76% |
| Rock Springs Capital Management LP | 721,500 | $52,186,000 | 1.31% |
| Integral Health Asset Management, LLC | 50,000 | $3,617,000 | 0.94% |
| Redmile Group, LLC | 411,017 | $29,729,000 | 0.93% |
| K2 PRINCIPAL FUND, L.P. | 114,800 | $8,303,000 | 0.72% |
| Connacht Asset Management LP | 18,762 | $1,357,000 | 0.70% |
| Perceptive Advisors | 477,037 | $34,504,000 | 0.69% |
| ArrowMark Colorado Holdings LLC | 855,439 | $61,874,000 | 0.54% |